Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: A meta-analysis

Epilepsia

Volumn 50, Issue 4, 2009, Pages 898-903

  Bournissen, Facundo Garcia ^a   Moretti, Myla E ^a   Juurlink, David N ^a   Koren, Gideon ^a   Walker, Mugabe ^a   Finkelstein, Yaron ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

ABCB1 C3435T; Epilepsy; MDR1; Meta analysis; Polymorphism

Indexed keywords

ANTICONVULSIVE AGENT; MULTIDRUG RESISTANCE PROTEIN 1;

ARTICLE; CLINICAL TRIAL; DNA POLYMORPHISM; EPILEPSY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; SEIZURE; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

ANTICONVULSANTS; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CROSS-CULTURAL COMPARISON; DATABASES, FACTUAL; DRUG RESISTANCE; EPILEPSY; HUMANS; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES;

EID: 63849243164     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2008.01858.x     Document Type: Article

References (30)

1. Balayssac D, Authier N, Cayre A, Coudore F 2005) Does inhibition of P-glycoprotein lead to drug-drug interactions? Toxicol Lett 156 : 319 329.
2. Berlin JA, Laird NM, Sacks HS, Chalmers TC 1989) A comparison of statistical methods for combining event rates from clinical trials. Stat Med 8 : 141 151.
3. Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W 2007) Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein. Neuropharmacology 52 : 333 346.
4. Chen L, Liu CQ, Hu Y, Xiao ZT, Chen Y, Liao JX 2007) Association of a polymorphism in MDR1 C3435T with response to antiepileptic drug treatment in ethic Han Chinese children with epilepsy. Zhongguo Dang Dai Er Ke Za Zhi 9 : 11 14.
5. Chowbay B, Li H, David M, Cheung YB, Lee EJ 2005) Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression. Br J Clin Pharmacol 60 : 159 171.
6. Database of Single Nucleotide Polymorphisms [dbSNP] 2007) National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD. http://www.ncbi.nlm.nih.gov/sites/entrez?db=snp.pubmed. Accessed on October 15, 2007.
7. Doran A, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E, Chen C, Chen X, Choo E, Cianfrogna J, Cox LM, Gibbs JP, Gibbs MA, Hatch H, Hop CE, Kasman IN, Laperle J, Liu J, Liu X, Logman M, Maclin D, Nedza FM, Nelson F, Olson E, Rahematpura S, Raunig D, Rogers S, Schmidt K, Spracklin DK, Szewc M, Troutman M, Tseng E, Tu M, Van Deusen JW, Venkatakrishnan K, Walens G, Wang EQ, Wong D, Yasgar AS, Zhang C 2005) The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model. Drug Metab Dispos 33 : 165 174.
8. Fromm MF 2000) P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38 : 69 74.
9. Fromm MF 2004) Importance of P-glycoprotein at blood-tissue barriers. Trends Pharmacol Sci 25 : 423 429.
10. Hajnsek S, Basic S, Poljakovic Z, Bozina N 2004) UTJECAJ C3435T POLIMORFIZMA MDR1 GENA NA UCINKOVITOST MEDIKAMENTNOG LIJECENJA EPILEPSIA. Neurol Croat 53 : 69 78.
11. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmoller J, Johne A, Cascorbi I, Gerloff T, Roots I, Eichelbaum M, Brinkmann U 2000) Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 97 : 3473 3478.
12. Hung CC, Tai JJ, Lin CJ, Lee MJ, Liou HH 2005) Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response. Pharmacogenomics 6 : 411 417.
13. Kim DW, Kim M, Lee SK, Kang R, Lee SY 2006a) Lack of association between C3435T nucleotide MDR1 genetic polymorphism and multidrug-resistant epilepsy. Seizure 15 : 344 347.
14. Kim YO, Kim MK, Woo YJ, Lee MC, Kim JH, Park KW, Kim EY, Roh YI, Kim CJ 2006b) Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics. Seizure 15 : 67 72.
15. Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui AC, Yu E, Wong LK 2007) Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav 11 : 112 117.
16. Leschziner GD, Andrew T, Leach JP, Chadwick D, Coffey AJ, Balding DJ, Bentley DR, Pirmohamed M, Johnson MR 2007) Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach. Pharmacogenet Genomics 17 : 217 220.
17. MacDonald BK, Johnson AL, Goodridge DM, Cockerell OC, Sander JW, Shorvon SD 2000) Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 48 : 833 841.
18. Marzolini C, Paus E, Buclin T, Kim RB 2004) Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin Pharmacol Ther 75 : 13 33.
19. Mayer U, Wagenaar E, Dorobek B, Beijnen JH, Borst P, Schinkel AH 1997) Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833. J Clin Invest 100 : 2430 2436.
20. Schinkel AH, Wagenaar E, Mol CA, van Deemter L 1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97 : 2517 2524.
21. Seo T, Ishitsu T, Ueda N, Nakada N, Yurube K, Ueda K, Nakagawa K 2006) ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients. Pharmacogenomics 7 : 551 561.
22. Shahwan A, Murphy K, Doherty C, Cavalleri GL, Muckian C, Dicker P, McCarthy M, Kinirons P, Goldstein D, Delanty N 2007) The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res 73 : 192 198.
23. Siddiqui A, Kerb R, Weale ME, Brinkmann U, Smith A, Goldstein DB, Wood NW, Sisodiya SM 2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 348 : 1442 1448.
24. Sills GJ, Mohanraj R, Butler E, McCrindle S, Collier L, Wilson EA, Brodie MJ 2005) Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment. Epilepsia 46 : 643 647.
25. Solas C, Simon N, Drogoul MP, Quaranta S, Frixon-Marin V, Bourgarel-Rey V, Brunet C, Gastaut JA, Durand A, Lacarelle B, Poizot-Martin I 2007) Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br J Clin Pharmacol 64 : 353 362.
26. Tan NC, Heron SE, Scheffer IE, Pelekanos JT, McMahon JM, Vears DF, Mulley JC, Berkovic SF 2004) Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63 : 1090 1092.
27. Thuerauf N, Fromm MF 2006) The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases. Eur Arch Psychiatry Clin Neurosci 256 : 281 286.
28. Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C 1995) MDR1 gene expression in brain of patients with medically intractable epilepsy. Epilepsia 36 : 1 6.
29. Woodahl EL, Ho RJ 2004) The role of MDR1 genetic polymorphisms in interindividual variability in P-glycoprotein expression and function. Curr Drug Metab 5 : 11 19.
30. Woodland C, Ito S, Koren G 1998) A model for the prediction of digoxin-drug interactions at the renal tubular cell level. Ther Drug Monit 20 : 134 138.